|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Johnson & Johnson |
JNJ |
478160104 |
Pharmaceuticals |
6,854 |
$1,068,607.14 |
7.55% |
| AbbVie Inc. |
ABBV |
00287Y109 |
Pharmaceuticals |
5,411 |
$1,047,082.61 |
7.39% |
| Merck & Co., Inc. |
MRK |
58933Y105 |
Pharmaceuticals |
12,260 |
$1,038,544.60 |
7.33% |
| Pfizer Inc. |
PFE |
717081103 |
Pharmaceuticals |
42,793 |
$1,018,045.47 |
7.19% |
| Bristol-Myers Squibb Company |
BMY |
110122108 |
Pharmaceuticals |
18,970 |
$933,703.40 |
6.59% |
| Eli Lilly and Company |
LLY |
532457108 |
Pharmaceuticals |
614 |
$543,512.80 |
3.84% |
| United Therapeutics Corporation |
UTHR |
91307C102 |
Pharmaceuticals |
1,767 |
$531,442.92 |
3.75% |
| Amgen Inc. |
AMGN |
031162100 |
Pharmaceuticals |
1,836 |
$529,796.16 |
3.74% |
| Zoetis Inc. |
ZTS |
98978V103 |
Pharmaceuticals |
3,381 |
$525,508.83 |
3.71% |
| Gilead Sciences, Inc. |
GILD |
375558103 |
Pharmaceuticals |
4,947 |
$515,526.87 |
3.64% |
| Viatris Inc. |
VTRS |
92556V106 |
Pharmaceuticals |
61,269 |
$510,983.46 |
3.61% |
| Biogen Inc. |
BIIB |
09062X103 |
Biotechnology |
4,025 |
$483,684.25 |
3.42% |
| Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Biotechnology |
809 |
$460,248.19 |
3.25% |
| Jazz Pharmaceuticals Plc |
JAZZ |
G50871105 |
Pharmaceuticals |
3,940 |
$458,655.40 |
3.24% |
| Organon & Co. |
OGN |
68622V106 |
Pharmaceuticals |
27,431 |
$360,991.96 |
2.55% |
| Exelixis, Inc. |
EXEL |
30161Q104 |
Biotechnology |
7,725 |
$297,798.75 |
2.10% |
| Medpace Holdings, Inc. |
MEDP |
58506Q109 |
Biotechnology |
859 |
$263,154.65 |
1.86% |
| Charles River Laboratories International, Inc. |
CRL |
159864107 |
Biotechnology |
1,963 |
$230,240.27 |
1.63% |
| Illumina, Inc. |
ILMN |
452327109 |
Biotechnology |
2,959 |
$228,138.90 |
1.61% |
| Elanco Animal Health Incorporated |
ELAN |
28414H103 |
Pharmaceuticals |
23,129 |
$225,276.46 |
1.59% |
| Halozyme Therapeutics, Inc. |
HALO |
40637H109 |
Biotechnology |
3,591 |
$218,404.62 |
1.54% |
| Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Biotechnology |
1,788 |
$191,745.12 |
1.35% |
| BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Pharmaceuticals |
2,780 |
$175,918.40 |
1.24% |
| Alkermes Plc |
ALKS |
G01767105 |
Pharmaceuticals |
5,046 |
$145,173.42 |
1.03% |
| Perrigo Company Plc |
PRGO |
G97822103 |
Pharmaceuticals |
5,138 |
$131,635.56 |
0.93% |
| Amneal Pharmaceuticals, Inc. |
AMRX |
03168L105 |
Pharmaceuticals |
15,042 |
$116,575.50 |
0.82% |
| ADMA Biologics, Inc. |
ADMA |
000899104 |
Biotechnology |
4,757 |
$114,691.27 |
0.81% |
| Prestige Consumer Healthcare Inc. |
PBH |
74112D101 |
Pharmaceuticals |
1,385 |
$113,473.05 |
0.80% |
| TG Therapeutics, Inc. |
TGTX |
88322Q108 |
Biotechnology |
2,591 |
$113,641.26 |
0.80% |
| Catalyst Pharmaceuticals, Inc. |
CPRX |
14888U101 |
Biotechnology |
4,636 |
$112,562.08 |
0.79% |
| Corcept Therapeutics Inc. |
CORT |
218352102 |
Pharmaceuticals |
1,287 |
$94,247.01 |
0.67% |
| Guardant Health, Inc. |
GH |
40131M109 |
Biotechnology |
1,832 |
$90,738.96 |
0.64% |
| Cardinal Health, Inc. |
CAH |
14149Y108 |
Pharmaceuticals |
602 |
$84,183.68 |
0.59% |
| Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Pharmaceuticals |
162 |
$81,567.00 |
0.58% |
| Alnylam Pharmaceuticals, Inc. |
ALNY |
02043Q107 |
Biotechnology |
316 |
$81,272.04 |
0.57% |
| Madrigal Pharmaceuticals, Inc. |
MDGL |
558868105 |
Biotechnology |
228 |
$77,702.40 |
0.55% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
Biotechnology |
1,644 |
$73,634.76 |
0.52% |
| Krystal Biotech, Inc. |
KRYS |
501147102 |
Biotechnology |
435 |
$74,197.95 |
0.52% |
| Blueprint Medicines Corporation |
BPMC |
09627Y109 |
Pharmaceuticals |
807 |
$71,403.36 |
0.50% |
| Veracyte, Inc. |
VCYT |
92337F107 |
Biotechnology |
2,243 |
$70,385.34 |
0.50% |
| PTC Therapeutics, Inc. |
PTCT |
69366J200 |
Biotechnology |
1,411 |
$69,872.72 |
0.49% |
| Akero Therapeutics, Inc. |
AKRO |
00973Y108 |
Biotechnology |
1,587 |
$68,304.48 |
0.48% |
| Insmed Incorporated |
INSM |
457669307 |
Biotechnology |
956 |
$68,258.40 |
0.48% |
| Axsome Therapeutics, Inc. |
AXSM |
05464T104 |
Biotechnology |
611 |
$67,158.07 |
0.47% |
| Scholar Rock Holding Corporation |
SRRK |
80706P103 |
Biotechnology |
2,008 |
$65,802.16 |
0.46% |
| Incyte Corporation |
INCY |
45337C102 |
Biotechnology |
1,061 |
$64,116.23 |
0.45% |
| SpringWorks Therapeutics, Inc. |
SWTX |
85205L107 |
Biotechnology |
1,350 |
$62,424.00 |
0.44% |
| Vericel Corporation |
VCEL |
92346J108 |
Biotechnology |
1,520 |
$59,827.20 |
0.42% |
| ACADIA Pharmaceuticals Inc. |
ACAD |
004225108 |
Biotechnology |
3,978 |
$57,402.54 |
0.41% |
| Sarepta Therapeutics, Inc. |
SRPT |
803607100 |
Biotechnology |
730 |
$44,420.50 |
0.31% |
| US Dollar |
$USD |
|
Other |
31,276 |
$31,275.57 |
0.22% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|